Article
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020-08-03
Abstract excerpt
We used two approaches to design proteins with shape and chemical complementarity to the receptor binding domain (RBD) of SARS-CoV-2 Spike protein near the binding site for the human ACE2 receptor. Scaffolds were built around an ACE2 helix that interacts with the RBD, or de novo designed scaffolds were docked against the RBD to identify new binding modes. In both cases, designed sequences were optimized first in s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5cb0a74d-2a18-579c-8d08-26d18c19e6e4
- DOI
- 10.1101/2020.08.03.234914
